Multicenter double-blind comparative study of terfenadine and cetirizine in hay fever. 1992

M F Caiaffa, and A Iudice, and L Macchia, and A Tursi, and G Vergallo, and G Sacerdoti, and A Venuti, and F Della Torre, and A Musarra
Dept. of Allergology, University of Bari, Italy.

The efficacy and safety of terfenadine in the management of hay fever were compared with those of cetirizine in a multicenter, double-blind, parallel-group study, carried out during the 1990 spring pollen season. The patients were randomly assigned to one of two groups of treatment, 70 patients being given terfenadine 120 mg, and 72 patients cetirizine 10 mg, once daily for 7 days. The severity of the main symptoms was evaluated at baseline and after treatment by a 4-point rating scale. In addition, the overall symptom severity was recorded daily by the patient on a diary card. Both terfenadine and cetirizine produced significant relief of symptoms by the end of treatment, with a decrease in symptom severity ranging from 46 to 69% for terfenadine and from 40 to 55% for cetirizine. Adverse effects experienced by terfenadine- and cetirizine-treated patients were mainly drowsiness, with minor differences between the two groups. The results of this study confirmed previous experiences, showing that both terfenadine and cetirizine once daily should be regarded as effective drugs for the management of hay fever.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006255 Rhinitis, Allergic, Seasonal Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS. Hay Fever,Pollen Allergy,Pollinosis,Seasonal Allergic Rhinitis,Hayfever,Allergic Rhinitides, Seasonal,Allergic Rhinitis, Seasonal,Allergies, Pollen,Allergy, Pollen,Fever, Hay,Pollen Allergies,Pollinoses,Rhinitides, Seasonal Allergic,Rhinitis, Seasonal Allergic,Seasonal Allergic Rhinitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012449 Safety Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property. Safeties

Related Publications

M F Caiaffa, and A Iudice, and L Macchia, and A Tursi, and G Vergallo, and G Sacerdoti, and A Venuti, and F Della Torre, and A Musarra
June 1993, Allergie et immunologie,
M F Caiaffa, and A Iudice, and L Macchia, and A Tursi, and G Vergallo, and G Sacerdoti, and A Venuti, and F Della Torre, and A Musarra
January 1995, Journal of investigational allergology & clinical immunology,
M F Caiaffa, and A Iudice, and L Macchia, and A Tursi, and G Vergallo, and G Sacerdoti, and A Venuti, and F Della Torre, and A Musarra
December 1989, Allergie et immunologie,
M F Caiaffa, and A Iudice, and L Macchia, and A Tursi, and G Vergallo, and G Sacerdoti, and A Venuti, and F Della Torre, and A Musarra
January 1989, The Journal of international medical research,
M F Caiaffa, and A Iudice, and L Macchia, and A Tursi, and G Vergallo, and G Sacerdoti, and A Venuti, and F Della Torre, and A Musarra
December 1990, Annals of allergy,
M F Caiaffa, and A Iudice, and L Macchia, and A Tursi, and G Vergallo, and G Sacerdoti, and A Venuti, and F Della Torre, and A Musarra
January 1985, The Journal of international medical research,
M F Caiaffa, and A Iudice, and L Macchia, and A Tursi, and G Vergallo, and G Sacerdoti, and A Venuti, and F Della Torre, and A Musarra
January 1987, The Journal of international medical research,
M F Caiaffa, and A Iudice, and L Macchia, and A Tursi, and G Vergallo, and G Sacerdoti, and A Venuti, and F Della Torre, and A Musarra
December 1991, Journal of investigational allergology & clinical immunology,
M F Caiaffa, and A Iudice, and L Macchia, and A Tursi, and G Vergallo, and G Sacerdoti, and A Venuti, and F Della Torre, and A Musarra
June 1972, Schweizerische medizinische Wochenschrift,
M F Caiaffa, and A Iudice, and L Macchia, and A Tursi, and G Vergallo, and G Sacerdoti, and A Venuti, and F Della Torre, and A Musarra
January 1980, The Journal of international medical research,
Copied contents to your clipboard!